Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22IFN-%CE%B2-1a%22&type=Subject&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22IFN-%CE%B2-1a%22&type=Subject&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22IFN-%CE%B2-1a%22&type=Subject&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (6)
1
Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic
enthalten in:
Acta neurologica Belgica
| 2024
von
Todorović, S.
|
Vojinović, S.
|
Savić, D.
| +2
Wird geladen...
2
Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic
enthalten in:
Acta neurologica Belgica
| 2023
von
Todorović, S.
|
Vojinović, S.
|
Savić, D.
| +2
Wird geladen...
3
Study of the effects of interferon β-1a on hospitalized patients with COVID-19 : SBMU Taskforce on the COVIFERON study
enthalten in:
Journal of medical virology
| 2022
von
Fallahzadeh, M.
|
Pourhoseingholi, M.
|
Boroujeni, M.
| +12
Wird geladen...
4
Potential COVID-19 Therapeutic Agents and Vaccines : An Evidence-Based Review
enthalten in:
Journal of clinical pharmacology
| 2021
von
Khani, E.
|
Khiali, S.
|
Entezari-Maleki, T.
Wird geladen...
5
Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
enthalten in:
International immunopharmacology
| 2021
von
Baghaei, P.
|
Dastan, F.
|
Marjani, M.
| +14
Wird geladen...
6
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection
enthalten in:
The Journal of infectious diseases
| 2020
von
Clementi, N.
|
Ferrarese, R.
|
Criscuolo, E.
| +7
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
2
Acta neurologica Belgica
1
International immunopharmacology
1
Journal of clinical pharmacology
1
Journal of medical virology
1
The Journal of infectious diseases
Alle anzeigen ...
weniger ...
Thema
5
Journal Article
4
Antiviral Agents
4
COVID-19
3
IFN-β1a
2
Antibodies, Monoclonal, Humanized
2
Disease-modifying therapy
2
IFN-β-1a
2
Interferon beta-1a
2
Multiple sclerosis
2
Ocrelizumab
2
SARS-CoV-2
2
XRO4566Q4R
1
2494G1JF75
1
77238-31-4
1
A10SJL62JY
1
Anti-Inflammatory Agents
1
Antibodies, Neutralizing
1
COVID-19 Vaccines
1
COVID-19 clinical trial
1
Covid-19
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
1
2023
1
2022
2
2021
1
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...